KIRSKE DAVID (Chief Financial Officer) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/14/2025ACC: 0001628280-25-040440
Officer· Chief Financial Officer
Since Aug 2025
+1.62M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.62M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+193.25K
Price / share
—
Trade value
—
% of position
New position
8/14/2025
0.00→193.25K
Total
Net shares
+193.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2025 | A · Award | +193.25K | — | — | New position | 0.00 | 193.25K |
| Total | +193.25K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.07M shares
Shares
+1.07M
Strike price
1.42
Held after
1.07M
Exercisable
—
8/12/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
352.80K shares
Shares
+352.80K
Strike price
3.14
Held after
352.80K
Exercisable
—
8/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.07M shares | 8/12/2025 | A · Award | +1.07M | 1.42 | — | 1.07M |
| Stock Option (right to buy) Direct | Common Stock352.80K shares | 8/14/2025 | A · Award | +352.80K | 3.14 | — | 352.80K |